-
1
-
-
0034091906
-
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation
-
Kawada T, Kitagawa H, Hoson M, Okada Y, Shiomura J (2000) Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation. Hematol Oncol Clin North Am 14: 445-457
-
(2000)
Hematol. Oncol. Clin. North Am.
, vol.14
, pp. 445-457
-
-
Kawada, T.1
Kitagawa, H.2
Hoson, M.3
Okada, Y.4
Shiomura, J.5
-
2
-
-
0027431280
-
Hypersensitivity to heparins; a case report
-
Katoh S, Terashima S, Nakahara Y, Yamada H, Tatsukawa H, Ida K, Nakagawa M (1993) Hypersensitivity to heparins; a case report. Nippon Jinzo Gakkai Shi 35:411-414
-
(1993)
Nippon Jinzo Gakkai Shi
, vol.35
, pp. 411-414
-
-
Katoh, S.1
Terashima, S.2
Nakahara, Y.3
Yamada, H.4
Tatsukawa, H.5
Ida, K.6
Nakagawa, M.7
-
3
-
-
0004007395
-
New anticoagulants for the cardiovascular patient
-
Hanley and Belfus, Philadelphia
-
Hoppensteadt DA, Jeske W, Fareed J (1997) New anticoagulants for the cardiovascular patient. Hanley and Belfus, Philadelphia, pp 521-538
-
(1997)
, pp. 521-538
-
-
Hoppensteadt, D.A.1
Jeske, W.2
Fareed, J.3
-
4
-
-
0025923636
-
Delayed elimination of enoxaparim in patients with chronic renal insufficiency
-
Cadroy Y, Pourrat J, Balandre MF, Saivin S, Houin G, Montastruc JL, Bonru B (1991) Delayed elimination of enoxaparim in patients with chronic renal insufficiency. Thromb Res 63:385-390
-
(1991)
Thromb. Res.
, vol.63
, pp. 385-390
-
-
Cadroy, Y.1
Pourrat, J.2
Balandre, M.F.3
Saivin, S.4
Houin, G.5
Montastruc, J.L.6
Bonru, B.7
-
5
-
-
0033057560
-
Association of heparin-induced skin lesions, intracutaneous tests, or induced IgG
-
Harenberg J, Huhle G, Wang L, Hoffmann U, Bayerl C, Kerowgan M (1999) Association of heparin-induced skin lesions, intracutaneous tests, or induced IgG. Allergy 54:473-477
-
(1999)
Allergy
, vol.54
, pp. 473-477
-
-
Harenberg, J.1
Huhle, G.2
Wang, L.3
Hoffmann, U.4
Bayerl, C.5
Kerowgan, M.6
-
6
-
-
0024471870
-
Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass
-
Zulys VJ, Teasdale SJ, Michel ER, Skala RA, Keating SE, Viger JR, Glynn MF (1989) Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Anesthesiology 71: 870-877
-
(1989)
Anesthesiology
, vol.71
, pp. 870-877
-
-
Zulys, V.J.1
Teasdale, S.J.2
Michel, E.R.3
Skala, R.A.4
Keating, S.E.5
Viger, J.R.6
Glynn, M.F.7
-
7
-
-
0029875562
-
Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy
-
Smith RE, Townsend GE, Berry BR, Bowan T (1996) Enoxaparin for unstable angina and ancrod for cardiac surgery following heparin allergy. Ann Pharmacother 30:476-480
-
(1996)
Ann. Pharmacother.
, vol.30
, pp. 476-480
-
-
Smith, R.E.1
Townsend, G.E.2
Berry, B.R.3
Bowan, T.4
-
8
-
-
0033937140
-
Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects
-
Swan SK, St Peter JV, Lambrecht LJ, Hursting MJ (2000) Comparison of anticoagulant effects and safety of argatroban and heparin in healthy subjects. Pharmacotherapy 20:756-770
-
(2000)
Pharmacotherapy
, vol.20
, pp. 756-770
-
-
Swan, S.K.1
St Peter, J.V.2
Lambrecht, L.J.3
Hursting, M.J.4
-
9
-
-
15144361588
-
Novastan (brand of argatroban): A small-molecule direct thrombin inhibitor
-
Hursting MJ, Alford KL, Becker JC, Brooks RL, Joffrion JL, Knappenberger GD, Kogan PW, Kogan TP, McKinney AA, Schwarz PP (1997) Novastan (brand of argatroban): a small-molecule direct thrombin inhibitor. Semin Thromb Hemost 23:503-516
-
(1997)
Semin. Thromb. Hemost.
, vol.23
, pp. 503-516
-
-
Hursting, M.J.1
Alford, K.L.2
Becker, J.C.3
Brooks, R.L.4
Joffrion, J.L.5
Knappenberger, G.D.6
Kogan, P.W.7
Kogan, T.P.8
McKinney, A.A.9
Schwarz, P.P.10
-
10
-
-
0029886137
-
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome
-
Lewis BE, Iaffaldano R, McKiernan TL, Rao L, Donkin J, Wallenga JM (1996) Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndrome. Cathet Cardiovasc Diagn 38:206-209
-
(1996)
Cathet. Cardiovasc. Diagn.
, vol.38
, pp. 206-209
-
-
Lewis, B.E.1
Iaffaldano, R.2
McKiernan, T.L.3
Rao, L.4
Donkin, J.5
Wallenga, J.M.6
-
11
-
-
0031719763
-
Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant Hirudin
-
Koster A, Kuppe H, Hetzer R, Sodian R, Crystal GJ, Mertzlufft F (1998) Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant Hirudin. Anesthesiology 89:777-780
-
(1998)
Anesthesiology
, vol.89
, pp. 777-780
-
-
Koster, A.1
Kuppe, H.2
Hetzer, R.3
Sodian, R.4
Crystal, G.J.5
Mertzlufft, F.6
-
13
-
-
0034053689
-
Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: A-year experience in 57 patients
-
Koster A, Hansen R, Kuppe H, Hetzer R, Crystal GJ, Mertzlufft F (2000) Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a-year experience in 57 patients. J Cardiothorac Vasc Anesth 14:243-248
-
(2000)
J. Cardiothorac. Vasc. Anesth.
, vol.14
, pp. 243-248
-
-
Koster, A.1
Hansen, R.2
Kuppe, H.3
Hetzer, R.4
Crystal, G.J.5
Mertzlufft, F.6
-
14
-
-
0027202439
-
"Heparin allergy" and cardiopulmonary bypass
-
(letter)
-
Bray JG. Jr (1993) "Heparin allergy" and cardiopulmonary bypass (letter). J Cardiothorac Vasc Anesth 7:505-506
-
(1993)
J. Cardiothorac. Vasc. Anesth.
, vol.7
, pp. 505-506
-
-
Bray J.G., Jr.1
|